The global short bowel syndrome market was valued at US$ 1.092.16 Mn in 2021 growing at a CAGR of 24.6% over the forecast period
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |